Effects of genetic variants previously associated with fasting glucose and insulin in the Diabetes Prevention Program. - Wikidata - awgldk - TriplyDB

Effects of genetic variants previously associated with fasting glucose and insulin in the Diabetes Prevention Program.

Effects of genetic variants previously associated with fasting glucose and insulin in the Diabetes Prevention Program.

http://www.wikidata.org/entity/Q34415887

about

New insights from monogenic diabetes for "common" type 2 diabetes Therapeutic Use of Metformin in Prediabetes and Diabetes Prevention Genetic and phenotypic correlations between surrogate measures of insulin release obtained from OGTT data.Large scale meta-analyses of fasting plasma glucose raising variants in GCK, GCKR, MTNR1B and G6PC2 and their impacts on type 2 diabetes mellitus risk.A common variant in the MTNR1b gene is associated with increased risk of impaired fasting glucose (IFG) in youth with obesity Genetic risk score of 46 type 2 diabetes risk variants associates with changes in plasma glucose and estimates of pancreatic β-cell function over 5 years of follow-up.The pharmacogenetics of type 2 diabetes: a systematic review.PROX1 gene CC genotype as a major determinant of early onset of type 2 diabetes in slavic study participants from Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation study.Stratified medicine for the use of antidiabetic medication in treatment of type II diabetes and cancer: where do we go from here?Meta-analyses of the association of G6PC2 allele variants with elevated fasting glucose and type 2 diabetes.Genetics of Type 2 Diabetes: It Matters From Which Parent We Inherit the Risk.The rs10885122 polymorphism of the adrenoceptor alpha 2A (ADRA2A) gene in Euro-Brazilians with type 2 diabetes mellitus.The combined effects of FADS gene variation and dietary fats in obesity-related traits in a population from the far north of Sweden: the GLACIER Study

P2860

Q26795455-5F0F0343-0667-46C7-B59A-A3760F892A2A Q26822066-A9CD6B6D-07D0-4E93-8E8B-4009A88D270E Q30889002-4FF9E7FC-2C2E-4604-B5CD-662ACABC0D38 Q34807904-8250374E-19EA-4989-B5BD-2AD9B454D4A8 Q35551571-2415ABC9-7A5A-4626-8F63-BAB9E2DDB3BF Q37193367-E3A870B4-815B-4004-86BF-07995EECA3D9 Q37597017-97A73515-C9C8-447B-8384-04675100790D Q37735321-837E0EBF-4F26-44A9-9D58-208DE9371B0E Q38270699-ED19DBEC-EE31-466B-AB7D-76B8108B77DE Q38680846-18F00308-8BA3-4BEC-88BE-79B3CBF03EC6 Q38816589-D75BC72F-FC65-4725-9F36-C11AE4DBB6AB Q55059081-7D5C12E2-36B6-4E45-A65C-931CF57EB809 Q57303437-875109B3-222C-4F19-A932-DA7B4D6EC015

P2860

Effects of genetic variants previously associated with fasting glucose and insulin in the Diabetes Prevention Program.

http://www.wikidata.org/entity/Q34415887

description

2012 nî lūn-bûn

@nan

2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Effects of genetic variants pr ...... e Diabetes Prevention Program.

@ast

Effects of genetic variants pr ...... e Diabetes Prevention Program.

@en

Effects of genetic variants pr ...... e Diabetes Prevention Program.

@nl

type

label

Effects of genetic variants pr ...... e Diabetes Prevention Program.

@ast

Effects of genetic variants pr ...... e Diabetes Prevention Program.

@en

Effects of genetic variants pr ...... e Diabetes Prevention Program.

@nl

prefLabel

Effects of genetic variants pr ...... e Diabetes Prevention Program.

@ast

Effects of genetic variants pr ...... e Diabetes Prevention Program.

@en

Effects of genetic variants pr ...... e Diabetes Prevention Program.

@nl

P1433

Q34415887-F9D784E1-7E1C-43D1-98CC-AAC4E535DADC

P1476

Q34415887-4B5D8F81-BD71-4F30-BC0C-9B03CC2B01D5

P2093

Q34415887-2338CFAC-A35B-4E57-972B-58679892E8EB

Q34415887-319FE0AF-0067-4B6A-84A4-00033AFFCBCE

Q34415887-72F9B404-69CD-42F0-B75D-1CCD30E793CB

Q34415887-7F101E04-7B7C-4BE6-9654-593A4E04BCE8

Q34415887-8A9E6E0D-CD3A-4EF3-AEA9-740DE5275730

Q34415887-9DBC18DA-AC3D-4D69-BD90-208F146C0856

Q34415887-B6BAC837-D0D7-4386-8217-B8B0836E15E2

Q34415887-E491B73A-292C-4087-A826-4C0DD2FDF3CF

P2860

Q34415887-03599EAC-5485-4433-AF30-511B28F0E34E

Q34415887-10806C46-B0FB-4B63-BA92-EC3329E97674

Q34415887-1DF975E0-39AB-428A-8E03-65A38DF4DA1C

Q34415887-2232E88A-970D-45D6-BF0D-E8462C7F542F

Q34415887-24A4BD42-97A3-464B-AD3E-C5C05F5141BA

Q34415887-36FB2096-F784-4E6C-857D-FE92898C8886

Q34415887-3A12A61F-0F7A-4984-BDA2-6C71250596D4

Q34415887-4AA1C850-5FE1-4387-96D6-E0EFC5602A7A

Q34415887-57544BC2-C566-4CA3-910F-9CFB7D154AAA

Q34415887-69325F7E-AA53-4845-B6EB-9A1B5D97ABA1

P304

Q34415887-DE226544-1D5D-41B5-9CBC-DFF13ACEC31A

P31

Q34415887-8E71ECAC-B80F-4699-A08A-4FD2AF036340

P356

Q34415887-BD2093A1-BDBD-4EBA-A148-7E355090050E

P407

Q34415887-C2214E96-11F4-4E3F-A53B-B88410EFE5E4

P433

Q34415887-DA9CAB1C-E3FA-407E-A9FB-DB1BC483583A

P478

Q34415887-80829010-A130-4F64-98DA-F20C8025BE95

P50

Q34415887-372A29AB-197B-49C9-8656-3BD39D315EEA

Q34415887-629F8C51-E5A4-4537-B328-134E80AAF24B

Q34415887-699B0E07-01B6-48F2-87EF-6908726AE06F

Q34415887-7C81F6EA-E02C-4022-9BC3-DB18ADA12CD8

Q34415887-7E0A7294-1B24-4CD2-B29C-E7D0725EC15A

Q34415887-93E78D21-06E1-4D4B-B696-120E438299AD

P577

Q34415887-BD09B90E-CC68-485A-ADB7-63D63482D14C

P5875

Q34415887-5ABCA346-5557-4B94-AF4D-19F3F917B868

P698

Q34415887-964D6289-5D4B-4248-A231-94DFD2688145

P932

Q34415887-601B3E72-625E-4A1E-A5A1-BF1AE7F41429

P356

JOURNAL.PONE.0044424

P1433

P1476

Effects of genetic variants pr ...... e Diabetes Prevention Program.

@en

P2093

Clinton C Mason

http://www.w3.org/2001/XMLSchema#string

Edward Horton

http://www.w3.org/2001/XMLSchema#string

Jarred B McAteer

http://www.w3.org/2001/XMLSchema#string

Jose C Florez

http://www.w3.org/2001/XMLSchema#string

Kathleen A Jablonski

http://www.w3.org/2001/XMLSchema#string

Kieren Mather

http://www.w3.org/2001/XMLSchema#string

Richard F Arakaki

http://www.w3.org/2001/XMLSchema#string

Ronald Goldberg

http://www.w3.org/2001/XMLSchema#string

P2860

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis

Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes

Variants in MTNR1B influence fasting glucose levels.

Common missense variant in the glucokinase regulatory protein gene is associated with increased plasma triglyceride and C-reactive protein but lower fasting glucose concentrations

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

A variant in the G6PC2/ABCB11 locus is associated with increased fasting plasma glucose, increased basal hepatic glucose production and increased insulin release after oral and intravenous glucose loads

New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk

Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge

Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels

P304

e44424

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0044424

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Alan R. Shuldiner

Diabetes Prevention Program Research Group

William C. Knowler

P577

2012-09-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230865084

http://www.w3.org/2001/XMLSchema#string

P698

22984506

http://www.w3.org/2001/XMLSchema#string

P932

3439414

http://www.w3.org/2001/XMLSchema#string